FOGPHARMA.COM: Keyword Density Checker

Total words: 533 | 2-word phrases: 139 | 3-word phrases: 144 | 4-word phrases: 145

PAGE INFO

Title	Try to keep the title under 60 characters (9 characters) FogPharma
Description	Try to keep the meta description between 50 - 160 characters (165 characters) FogPharma is a clinical-stage company pioneering a new class of drugs to address the limitations of today’s precision medicines and achieve universal druggability.
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (32 characters) Achieving Universal Druggability

#	Keyword	Frequency	Density
1	precision medicines and	2	1.39%
2	today’s precision medicines	2	1.39%
3	of today’s precision	2	1.39%
4	limitations of today’s	2	1.39%
5	a new class	2	1.39%
6	new class of	2	1.39%
7	skip to main	1	0.69%
8	and intracellular target	1	0.69%
9	the broad tissue	1	0.69%
10	distribution and intracellular	1	0.69%
11	engagement of small	1	0.69%
12	intracellular target engagement	1	0.69%
13	target engagement of	1	0.69%
14	antibodies with the	1	0.69%
15	of small molecules	1	0.69%
16	small molecules to	1	0.69%
17	with the broad	1	0.69%
18	of antibodies with	1	0.69%
19	and reach the	1	0.69%
20	science achieving universal	1	0.69%
21	targets across virtually	1	0.69%
22	to main content	1	0.69%
23	virtually all disease	1	0.69%
24	all disease areas	1	0.69%
25	disease areas view	1	0.69%
26	our science achieving	1	0.69%
27	achieving universal druggability	1	0.69%
28	specificity of antibodies	1	0.69%
29	universal druggability helicons	1	0.69%
30	druggability helicons combine	1	0.69%

#	Keyword	Frequency	Density
1	of today’s precision medicines	2	1.38%
2	today’s precision medicines and	2	1.38%
3	limitations of today’s precision	2	1.38%
4	a new class of	2	1.38%
5	engagement of small molecules	1	0.69%
6	target engagement of small	1	0.69%
7	intracellular target engagement of	1	0.69%
8	and intracellular target engagement	1	0.69%
9	distribution and intracellular target	1	0.69%
10	with the broad tissue	1	0.69%
11	antibodies with the broad	1	0.69%
12	of antibodies with the	1	0.69%
13	specificity of antibodies with	1	0.69%
14	and specificity of antibodies	1	0.69%
15	strength and specificity of	1	0.69%
16	druggability helicons combine the	1	0.69%
17	targeting strength and specificity	1	0.69%
18	universal druggability helicons combine	1	0.69%
19	achieving universal druggability helicons	1	0.69%
20	science achieving universal druggability	1	0.69%
21	our science achieving universal	1	0.69%
22	all disease areas view	1	0.69%
23	virtually all disease areas	1	0.69%
24	across virtually all disease	1	0.69%
25	to main content fogpharma	1	0.69%
26	intractable targets across virtually	1	0.69%
27	previously intractable targets across	1	0.69%
28	helicon therapeutics against important	1	0.69%
29	novel helicon therapeutics against	1	0.69%
30	advance novel helicon therapeutics	1	0.69%
31	of small molecules to	1	0.69%
32	skip to main content	1	0.69%
33	precision medicines and reach	1	0.69%
34	our lead program	1	0.69%
35	clinical trial view our	1	0.69%
36	12 clinical trial view	1	0.69%
37	phase 12 clinical trial	1	0.69%
38	a phase 12 clinical	1	0.69%
39	in a phase 12	1	0.69%
40	evaluated in a phase	1	0.69%

#	URL	Whois	Check
1	https://www.linkedin.com/company/fog-pharmaceuticals	Whois	linkedin.com